Association between nk cells and response to anti-cd20 medications in multiple sclerosis patients

被引：0

作者：

Casanova Peno, Ignacio ^{[1
,2
]}

Dominguez Mozo, Maria Inmaculada ^{[3
]}

Garcia-Martinez, Maria Angel ^{[3
]}

de la Cuesta, David ^{[3
]}

Abellan, Sara ^{[1
]}

Donas Jimenez, Maria Teresa Garcia ^{[4
]}

Rius Hernandez, Irina ^{[4
]}

Minano, Elena ^{[2
]}

Lopez-Ruiz, Pedro ^{[2
]}

Arroyo, Rafael ^{[2
]}

Alvarez-Lafuente, Roberto ^{[3
]}

机构：

[1] Hosp Univ Torrejon, Dept Neurol, Madrid, Spain

[2] Quironsalud Madrid Univ Hosp, Dept Neurol, Madrid, Spain

[3] Hlth Res Inst Hosp Clin San Carlos IdISSC, Res Grp Environm Factors Neurodegenerat Dis, Madrid, Spain

[4] Hosp Univ Torrejon, Res Unit, Madrid, Spain

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1420/2357

引用

页码：904 / 905

页数：2

共 50 条

[1] Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications
Moser, T.
Otto, F.
Pilz, G.
Wipfler, P.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 395 - 395
[2] Anti-CD20 monoclonal antibodies in multiple sclerosis
Moreno Torres, Irene
Garcia-Merino, Antonio
[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
[3] Anti-CD20 antibody wows in multiple sclerosis
Sheridan, Cormac
[J]. NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
[4] Anti-CD20 antibody wows in multiple sclerosis
Cormac Sheridan
[J]. Nature Biotechnology, 2015, 33 : 1215 - 1216
[5] Development of anti-CD20 therapy for multiple sclerosis
Bartok, Beatrix
Silverman, Gregg J. J.
[J]. EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1312 - 1318
[6] Treatment of multiple sclerosis with Anti-CD20 antibodies
Barun, Barbara
Bar-Or, Amit
[J]. CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
[7] Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy
Waede, Mie
Voss, Lasse F.
Kingo, Christina
Moeller, Jesper B.
Elkjaer, Maria L.
Illes, Zsolt
[J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024,
[8] Ublituximab: a new anti-CD20 agent for multiple sclerosis
Oh, Jiwon
Bar-Or, Amit
[J]. LANCET NEUROLOGY, 2022, 21 (12): : 1070 - 1072
[9] A personalized approach for anti-CD20 therapies in multiple sclerosis
Hogenboom, Laura
Kempen, Zoe L. E. van
Kalincik, Tomas
Bar-Or, Amit
Killestein, Joep
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
[10] Can NK cells play a role in anti-CD20 immunotherapy for CLL patients?
Le Garff-Tavemier, Magali
De Romeuf, Christophe
Teillaud, Jean-Luc
Decocq, Julie
Dutertre, Charles-Antoine
Debre, Patrice
Merle-Beral, Helene
Vieillard, Vincent
[J]. BLOOD, 2007, 110 (11) : 913A - 913A

← 1 2 3 4 5 →